H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Histamine is a monoamine synthesized from the amino acid histidine that is well-known for its role in IgE-mediated anaphylaxis but has shown pleiotropic effects on the immune system, especially in order to promote inflammatory responses. H1-receptor antagonist are common drugs used in mild/moderate allergic reactions whereas H2-receptor antagonist are commonly administered in gastric ulcer but showed some properties in allergy too. The EAACI guidelines for diagnosis and treatment of anaphylactic reactions recommend their use as third-line therapy in adjunct to H1-antagonists. The purpose of this article is to produce a complete summary of findings and evidence known so far about the usefulness of H2-receptor antagonist in allergic reactons.

Cite

CITATION STYLE

APA

Borro, M., Negrini, S., Long, A., Chinthrajah, S., & Murdaca, G. (2021, December 1). H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far? Clinical and Molecular Allergy. BioMed Central Ltd. https://doi.org/10.1186/s12948-021-00143-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free